Lysine 322 in the human IgG3 CH2 domain is crucial for antibody dependent complement activation

Molecular Immunology

Volumn 37, Issue 16, 2000, Pages 995-1004

  Thommesen, John E ^a   Michaelsen, Terje E ^a,b   Loset, Geir Åge ^a   Sandlie, Inger ^a   Brekke, Ole H ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Antibodies; Complement; Human

Indexed keywords

AMINO ACID; ASPARTIC ACID 280; GLUTAMINE 318; GLUTAMINE 333; IMMUNOGLOBULIN G3; LYSINE 276; LYSINE 320; LYSINE 322; LYSINE DERIVATIVE; TYROSINE 278; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; BINDING SITE; BLOOD LEVEL; CELL LEVEL; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION; CONTROLLED STUDY; HUMAN; LYSIS; MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; TARGET CELL;

EID: 0034983614     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(01)00010-4     Document Type: Article

References (37)

1. The use of a hapten-Fab conjugate to sensitize target cells for antibody-dependent complement-mediated lysis and antibody-dependent cell-mediated cytotoxicity
2. Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis
3. The first component of complement from the bullfrog, Rana catesbeiana: Functional properties of C1- and isolation of subcomponent C1q
4. An IgG primary sequence exposure theory for complement activation using synthetic peptides
5. Activation of complement by an IgG molecule without a genetic hinge
6. The structural requirements for complement activation by IgG: Does it hinge on the hinge
7. Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis
8. The Clq receptor site on immunoglobulin G
9. The improved lytic function and in vivo efficacy of monovalent monoclonal CD3 antibodies
10. Characterization of a plasmin-digest fragment of rabbit immunoglobulin gamma that binds antigen and complement
11. A new enzymic fragment (Facb) of rabbit immunoglobulin G
12. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution
13. The binding site for C1q on IgG
14. Comparison of intact antibody structures and the implications for effector function
15. Rat Clq: Similarity to human Clq in functional and compositional properties
16. Effect of H chain V region on complement activation by immobilized immune complexes
17. The reaction between the complement subcomponent C1q, IgG complexes and polyionic molecules
18. Mapping of the C1q binding site on Rituxan: A chimeric antibody with a human IgG1 Fc
19. Therapy with monoclonal antibodies. II. The contribution of Fc gamma receptor binding and the influence of C(H)1 and C(H)3 domains on in vivo effector function
20. IgG-Fc-mediated effector functions: Molecular definition of interaction sites for effector ligands and the role of glycosylation
21. Rapid and efficient site-specific mutagenesis without phenotypic selection
22. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
23. Identification and characterisation of C1q-binding phage displayed peptides
24. Inhibition of C1-mediated immune hemolysis by monomeric and dimeric peptides from the second constant domain of human immunoglobulin G
25. One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge
26. Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse- human IgG subclasses and IgG3 antibodies with altered hinge region
27. Enhancement of complement activation and cytolysis of human IgG3 by deletion of hinge exons
28. H2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding
29. Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells
30. Functional affinity constants of subfragments of immunoglobulin G for Clq
31. The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcgRIII complex
32. H2 domain
33. Structural features of human immunoglobulin G that determine isotype- specific differences in complement activation
34. Co-operation between the pair of C gamma 2 domains in Clq-binding by rabbit IgG
35. Preparation and biologic characterization of fragments containing dimeric and monomeric C gamma 2 domain of rabbit IgG
36. Recombinant mouse monoclonal antibodies with single amino acid substitutions affecting Clq and high affinity Fc receptor binding have identical serum half-lives in the BALB/c mouse
37. The structure and function of immunoglobulin domains. IV. The distribution of some effector functions among the Cgamma2 and Cgamma3 homology regions of human immunoglobulin G1